#UP vaccination

[dillyt]

Great news for uninsured adults in the USA who want a COVID-19 booster! It now appears that ALL CVS locations are now active participants in the Bridge Access Program. The Bridge Access Program gives out free Covid-19 vaccinations to 18+ adults who otherwise can't afford one, so if you have a CVS near you, please go get one! For others who don't have a CVS near them, please go to vaccines.gov, click on "Find Covid-19 vaccines", fill out which vaccines you prefer (you can mix different vaccines if you have to so i reccomend just marking all of them for the age groups you need), and when the next page loads mark the "Bridge Access Program Participant" option to see only locations that are Bridge Access Program participants. Hopefully, other places that aren't CVS will start participating soon, so just check back every so often to see if there are any updates. The CDC Bridge Access Program website also has more details on what locations will be participating, but only CVS is appearing as an active participant on the vaccines.gov location finder at the moment.

[brightlotusmoon]

[gumjrop]

This year’s flu shot will be missing a strain of influenza it’s protected against for more than a decade.

That’s because there have been no confirmed flu cases caused by the Influenza B/Yamagata lineage since spring 2020. And the Food and Drug Administration decided this year that the strain now poses little to no threat to human health.

Scientists have concluded that widespread physical distancing and masking practiced during the early days of COVID-19 appear to have pushed B/Yamagata into oblivion.

This surprised many who study influenza, as it would be the first documented instance of a virus going extinct due to changes in human behavior, said Dr. Rebecca Wurtz, an infectious disease physician and epidemiologist at the University of Minnesota School of Public Health.

“It is such an interesting and unique story,” Wurtz said, adding that if it were not for COVID, B/Yamagata would still be circulating.

One reason COVID mitigation efforts were so effective at eliminating B/Yamagata is there was already a fair amount of immunity in the population against this strain of flu, which was also circulating at a lower level, said Dr. Kawsar Talaat, an infectious disease physician at Johns Hopkins Bloomberg School of Public Health.

In contrast, SARS-CoV-2 was a brand new virus that no one had encountered before; therefore, masking and isolation only slowed its transmission, but did not stop it.

The absence of B/Yamagata won’t change the experience of getting this year’s flu shot, which the Centers for Disease Control and Prevention recommends to everyone over 6 months old. And unvaccinated people are no less likely to get the flu, as B/Victoria and two influenza A lineages are still circulating widely and making people sick. Talaat said the disappearance of B/Yamagata doesn’t appear to have lessened the overall burden of flu, noting that the level of illness that can be attributed to any strain varies from year to year.

The CDC estimates that between 12,000 and 51,000 people die every year from influenza.

However, the manufacturing process is simplified now that the vaccine is trivalent — designed to protect against three flu viruses — instead of quadrivalent, protecting against four. That change allows more doses to be produced, said Talaat.

Ultimately, the costs of continuing to include protection against B/Yamagata in the flu shot outweigh its benefits, said Talaat.

"If you include a strain for which you don't think anybody's going to get infected into a vaccine, there are some potential risks and no potential benefits," she said. "Even though the risks might be infinitesimal, the benefits are also infinitesimal."

Scientists and public health experts have discussed for the past couple years whether to pull B/Yamagata from the flu vaccine or wait for a possible reemergence, said Kevin R. McCarthy, an assistant professor at the University of Pittsburgh's Center for Vaccine Research. But McCarthy agrees that continuing to vaccinate people against B/Yamagata does not benefit public health.

Additionally, there is a slight chance of B/Yamagata accidentally infecting the workers who manufacture the flu vaccine. The viruses, grown in eggs, are inactivated before being put into the shots: You cannot get influenza from the flu shot. But worker exposure to live B/Yamagata might occur before it's rendered harmless.

That hypothetically could lead to a reintroduction of a virus that populations have waning immunity to because B/Yamagata is no longer making people sick. While that risk is very low, McCarthy said it doesn’t make sense to produce thousands of gallons of a likely extinct virus.

It is possible that B/Yamagata continues to exist in pockets of the world that have less comprehensive flu surveillance. However, scientists aren’t worried that it is hiding in animals because humans are the only host population for B lineage flu viruses.

Scientists determined that B/Yamagata disappeared in a relatively short period of time, and this in and of itself is a success, said McCarthy. That required collaboration and data sharing from people all over the world, including countries that the U.S. has more tenuous diplomatic relationships with, like China and Russia.

“I think the fact that we can do that shows that we can get some things right,” he said.

Sarah Boden is an independent health and science journalist based in Pittsburgh.

[cracklewink]

Part 4/5 of my MLP Infection AU!!

This was the part I was most excited for, I literally drew this whole thing just to explain my fan pony species lol

[nando161mando]

[truth4ourfreedom]

JAPANESE DR TELLS IT LIKE IT IS ABOUT COVID VACCINES!

The word is spreading! He talks about how Moderna is dumping vaccines because no one will take them and about Fauci. Please like and repost!

[trainforanother1000years]

my prediction for Richas and Pomme’s Excellent Adventure

[covid-safer-hotties]

FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants - Published Aug 22, 2024

Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX Inc. and Pfizer Inc.

In early June, the FDA advised manufacturers of licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 formula) should be monovalent JN.1 vaccines. Based on the further evolution of SARS-CoV-2 and a rise in cases of COVID-19, the agency subsequently determined and advised manufacturers that the preferred JN.1-lineage for the COVID-19 vaccines (2024-2025 formula) is the KP.2 strain, if feasible.

“Vaccination continues to be the cornerstone of COVID-19 prevention,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “These updated vaccines meet the agency’s rigorous, scientific standards for safety, effectiveness, and manufacturing quality. Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants.”

The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, both of which are authorized for emergency use for individuals 6 months through 11 years of age.

What You Need to Know

=Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated, authorized Moderna COVID-19 Vaccine.

=Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of the updated, authorized Moderna or =Pfizer-BioNTech COVID-19 vaccines (timing and number of doses to administer depends on the previous COVID-19 vaccine received).

=Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines; if previously vaccinated, the dose is administered at least 2 months after the last dose of any COVID-19 vaccine.

=Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty or the updated, approved Spikevax; if previously vaccinated, the dose is administered at least 2 months since the last dose of any COVID-19 vaccine.

=Additional doses are authorized for certain immunocompromised individuals ages 6 months through 11 years of age as described in the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine fact sheets.

=Individuals who receive an updated mRNA COVID-19 vaccine may experience similar side effects as those reported by individuals who previously received mRNA COVID-19 vaccines and as described in the respective prescribing information or fact sheets. The updated vaccines are expected to provide protection against COVID-19 caused by the currently circulating variants. Barring the emergence of a markedly more infectious variant of SARS-CoV-2, the FDA anticipates that the composition of COVID-19 vaccines will need to be assessed annually, as occurs for seasonal influenza vaccines.

For today’s approvals and authorizations of the mRNA COVID-19 vaccines, the FDA assessed manufacturing and nonclinical data to support the change to include the 2024-2025 formula in the mRNA COVID-19 vaccines. The updated mRNA vaccines are manufactured using a similar process as previous formulas of these vaccines. The mRNA COVID-19 vaccines have been administered to hundreds of millions of people in the U.S., and the benefits of these vaccines continue to outweigh their risks.

On an ongoing basis, the FDA will review any additional COVID-19 vaccine applications submitted to the agency and take appropriate regulatory action.

The approval of Comirnaty (COVID-19 Vaccine, mRNA) (2024-2025 Formula) was granted to BioNTech Manufacturing GmbH. The EUA amendment for the Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) was issued to Pfizer Inc.

The approval of Spikevax (COVID-19 Vaccine, mRNA) (2024-2025 Formula) was granted to ModernaTX Inc. and the EUA amendment for the Moderna COVID-19 Vaccine (2024-2025 Formula) was issued to ModernaTX Inc.

[halorvic]

[zu-is-here]

* A serrade petit cat appears! (ò_ó")

[mothhuuny]

laishuro is like a unique breed of toxic yaoi that im coining as "vaccine yaoi" which is, yaoi that was toxic at some point, but after beating eachother up, they are now a little bit more healthy. not fully untoxic yet, but in a healthy way. like how most medicines are made out of a little bit of poison. vaccine yaoi.

(this same concept can absolutely be applied to yuri, but laios and toshiro are the two that inspired this name for me)

[impishtubist]

So I know that James and Sirius's friendship is fundamental to Sirius's character, but bear with me: a universe where James, Lily, Sirius, and Remus never met. Maybe Remus was homeschooled, maybe Sirius went to another school, whatever. James and Lily still die, and Harry gets shipped off to the Dursleys with no godfather.

Years later, when he starts Hogwarts, he likes all his teachers, but he REALLY likes his DADA professor, Professor Black. Professor Black met his husband Remus after the war and they live in a cute little cottage in Hogsmeade, where Remus tends to their menagerie of frankly terrifying magical plants and creatures, and Professor Black teaches.

And Sirius is drawn to this scrawny, too-thin kid who very obviously does not have a good home life. He starts being friendly with Harry, inviting him to his office for tea, helping him with his assignments, probing a bit into his home life, but not too much, because he doesn't want Harry to shut down. Harry stays at Hogwarts over the holiday breaks, so Sirius stays too. He's really suspicious of the Dursleys, and keeps badgering McGonagall to let him take Harry for a break - maybe Easter, or a week in the summer. Harry gets to know his professor and Mr. Lupin really well, and always looks forward to seeing them/staying with them. Eventually, Remus clandestinely manages to gather enough evidence that the Dursleys are mistreating Harry, and Sirius makes a move for custody.

Basically, I love Sirius and Harry finding each other in every universe, even if Sirius doesn't know James or Lily 🥺

[oifaaa]

Anyway the good news is I'm vaccinated the bad news is that I have two younger siblings

[jahsontodd]

Ummmm Nicki didn’t marry that man last week why are y’all saying you’re done with her now

[reality-detective]

The military personnel were/are the lab rats, but everything has been scripted to end the lives of billions of people. 🤔

[youngpettyqueen]

Julian and Keiko headcanons because Keiko gets sidelined so much and deserves the world and I wish we got to see them interact more

when they get stumped on their respective projects, they'll do late night work sessions together and bounce their research off each other to see if the other can help them figure out where the problem is. they'll do this in person when theyre both on the station, but also over call if one of them is away, and after the O'Briens move back to Earth

they edit each other's papers (Keiko marvels at Julian's ability to spell out complex chemical compounds with his eyes closed, and somehow use 'their' instead of 'there') (in his defense he wrote that bit at 4 in the morning after going 2 straight days without sleep) (she threatens to sedate him)

Julian sometimes brings back plants from planets they explore in the Gamma Quadrant and gives them to Keiko. sometimes he does it because the plant has medicinal properties and the two of them can do a joint research project, but most of the time he does it just to give her a nice gift

when Miles goes away for particularly dangerous missions, Julian will keep Keiko company and help keep her mind off of it. sometimes she has trouble sleeping because shes so worried, so he'll hang around and start rambling on about whatever he's currently working on until she falls asleep. he jokes he's boring her to sleep, but it actually means a lot to her

they have a weekly tea date. this is their prime gossip time. sometimes Jadzia is invited

when Keiko's mad at Miles she'll rant to Julian about it. Julian learned very quickly that this is not a time where advice is wanted, so he sits back and lets her get it all off her chest, because she really just wants someone to listen and let her blow off some steam

Julian makes a concentrated effort to learn more about plant husbandry and care after the incident where he accidentally killed some of Keiko's prized plants because he actually does feel very bad about it

Julian hovered over Keiko nearly as bad as Miles did when she was pregnant with Kirayoshi (and then he hovered over her even more after the pregnancy transfer, and he wouldnt tell anybody why, but Keiko knew it was because nearly losing her shook him up pretty bad)

when Julian gets outed for being augmented, Keiko goes to him and gives him the tightest, warmest hug he's ever gotten in his entire life

Julian gets invited to girls nights with Keiko and Molly (steady surgeon's hands make him the best one to paint nails) (he pretends to complain but he loves it)

anytime Julian has to go away for a scientific conference of any kind, if he gets to bring someone with him, his first choice is always Keiko

in short: theyre besties they told me so themselves <3